Insmed (INSM) Tops Q1 EPS by 17c ; Offers Guidance
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $121.55 --0%
EPS Growth %: +77.7%
Financial Fact:
Income tax expense: 25K
Today's EPS Names:
OCCI, IPX, ALZN, More
EPS Growth %: +77.7%
Financial Fact:
Income tax expense: 25K
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q1 EPS of ($1.06), $0.17 better than the analyst estimate of ($1.23). Revenue for the quarter came in at $75.5 million versus the consensus estimate of $78.51 million.
GUIDANCE:
Insmed sees FY2024 revenue of $340-360 million, versus the consensus of $354.7 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Assumes Insmed (INSM) at Buy
- HB Fuller (FUL) PT Lowered to $65 at Baird
- Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
